26
|
Persigehl T, Kellert J, Wall A, Matuszewski L, Winkelmann S, Heindel W, Bremer C, Dahnke H. Bestimmung des Tumor-Blutvolumens mittels einer optimierten MR-Relaxometrie Multi-Gradienten Echo Sequenz. ROFO-FORTSCHR RONTG 2008. [DOI: 10.1055/s-2008-1073685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Buerke B, Bremer C, Evers S, Allkemper T, Vogt M, Heindel W, Tombach B. CE-MRA der supraaortalen Arterien mit Gadovist®, Omniscan®, Multihance® and Vasovist®: Ergebnisse einer prospektiven intraindividuellen Vergleichsstudie. ROFO-FORTSCHR RONTG 2008. [DOI: 10.1055/s-2008-1073679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Faust A, Waschkau B, Waldeck J, Breyholz HJ, Kopka K, Heindel W, Schäfers M, Bremer C. Synthese und Evaluation von fluoreszenzmarkierten Barbituraten für die optische Bildgebung von Matrix-Metalloproteinasen. ROFO-FORTSCHR RONTG 2008. [DOI: 10.1055/s-2008-1073994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
29
|
Buerke B, Allkemper T, Kugel H, Bremer C, Heindel W, Tombach B. Wie verlässlich sind Signalintensitätsmessungen in der mit Software-Algorithmen (CLEAR) nachverarbeiteten CE-MRA? ROFO-FORTSCHR RONTG 2008. [DOI: 10.1055/s-2008-1073532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Eisenblätter M, Vogl T, Heindel W, Roth J, Bremer C. MRP-Targetting in toxischem Kontaktekzem – ein Mausmodell zur Bildgebung der Entzündung in vivo. ROFO-FORTSCHR RONTG 2008. [DOI: 10.1055/s-2008-1073740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
31
|
Thoennissen NH, Schliemann C, Brunnberg U, Schmidt E, Staebler A, Stegger L, Bremer C, Schleicher C, Mesters RM, Müller-Tidow C, Berdel WE. Chemotherapy in metastatic malignant triton tumor: report on two cases. Oncol Rep 2007; 18:763-7. [PMID: 17786333 DOI: 10.3892/or.18.4.763] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Malignant triton tumor (MTT) is a rare, highly malignant nerve sheath tumor with rhabdomyoblastic differentiation. Initial debulking surgery followed by adjuvant therapy is the current treatment of choice, but has very limited efficacy when optimal cytoreduction is not achieved by surgical procedure. Neoadjuvant therapy for MTT, to potentially facilitate subsequent surgery, eradicate micrometastatic lesions and, therefore, improve the therapeutical outcome, has never before been presented in literature. Here, we report on the multimodal management of two cases of advanced and metastatic MTT. Treatment modalities involved neoadjuvant and adjuvant chemotherapy, surgical resection, and radiation. In both cases, integrated Positron Emission Tomography/Computed Tomography (PET/CT) emerged as an important diagnostic tool for the reliable assessment of MTT response and metabolic remission.
Collapse
|
32
|
Abstract
Superparamagnetic iron oxide (SPIO) contrast agents, clinically established for high resolution magnetic resonance imaging of reticuloendothelial system containing anatomical structures, can additionally be exploited for the non-invasive characterization and quantification of pathology down to the molecular level. In this context, SPIOs can be applied for non-invasive cell tracking, quantification of tissue perfusion and target specific imaging, as well as for the detection of gene expression. This article provides an overview of new applications for clinically approved iron oxides as well of new, modified SPIO contrast agents for parametric and molecular imaging.
Collapse
|
33
|
Waldeck J, von Wallbrunn A, Hoeltke C, Zühlsdorf M, Heindel W, Schäfers M, Bremer C. In vivo Fluoreszenzbildgebung der CD13/APN-Expression im Tumor-Xenograft. ROFO-FORTSCHR RONTG 2007. [DOI: 10.1055/s-2007-977346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
34
|
Buerke B, Allkemper T, Kugel H, Heindel W, Bremer C, Tombach B. Intraindividueller Vergleich von 2 Injektionsraten für die CE-MRA der supraaortalen Arterien mit 1,0M Gadovist®. ROFO-FORTSCHR RONTG 2007. [DOI: 10.1055/s-2007-976918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
35
|
Höltke C, von Wallbrunn A, Faust A, Kopka K, Schäfers M, Bremer C. In Vivo Bildgebung der Endothelin-Rezeptor Expression humaner Brustkrebszelllinien in Xenograft-Mausmodellen. ROFO-FORTSCHR RONTG 2007. [DOI: 10.1055/s-2007-977339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
Eisenblätter M, Wall A, Ehrchen J, Heindel W, Roth J, Bremer C. Fluoreszenz-basierte Visualisierung von Leukozyten-Migration in inflammatorische Granulome. ROFO-FORTSCHR RONTG 2007. [DOI: 10.1055/s-2007-976991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
37
|
Wülfing P, Smollich M, Meyer V, Götte M, Bremer C, Kiesel L. Therapeutisches Targeting des Endothelin-A-Rezeptors beim Mammakarzinom in vivo. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
38
|
Bremer C. MRT-Kontrastmittel: Neue Entwicklungen. ROFO-FORTSCHR RONTG 2006. [DOI: 10.1055/s-2006-940453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
39
|
Persigehl T, Matuszewski L, Wall AW, Kessler T, Bieker R, Berdel W, Mesters R, Heindel W, Bremer C. Prognostische Wertigkeit der USPIO unterstützten MRT zur Abschätzung anti-angiogener Tumortherapie. ROFO-FORTSCHR RONTG 2006. [DOI: 10.1055/s-2006-940757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
von Wallbrunn AW, Höltke C, Zühlsdorf M, Heindel W, Schäfers M, Bremer C. Fluoreszenz-Bildgebung der αvβ3-Expression mit planaren und tomographischen Methoden. ROFO-FORTSCHR RONTG 2006. [DOI: 10.1055/s-2006-941129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
41
|
Wall AW, Licha K, Schirner M, von Wallbrunn AW, Persigehl T, Matuszewski L, Heindel W, Bremer C. Bestimmung des Angioneogenese – Grades in Brustkrebs-Xenograft – Modellen mit einem neuen optischen Kontrastmittel „SIDAG“ (NIR96010). ROFO-FORTSCHR RONTG 2006. [DOI: 10.1055/s-2006-940817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
42
|
Matuszewski L, Kuhlpeter R, Dahnke H, Persigehl T, Wall A, Heindel W, Schaeffter T, Bremer C. T2/T2*-Mapping zur Quantifizierung eisenmarkierter Zellen im Hochfeld-MRT. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-867771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
43
|
Persigehl T, Matuszewski L, Wall A, Wülfing C, Tombach B, Mesters R, Heindel W, Bremer C. Abschätzung der Therapieeffektivität antiangiogener Tumortherapien mittels Diffusion-gewichteter MRT. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-867688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
44
|
Abstract
With an increasing understanding of the molecular basis of disease, various new imaging targets have recently been defined that potentially allow for an early, sensitive, and specific diagnosis of disease or monitoring of treatment response. Different approaches to depict these molecular structures in vivo are currently being explored by the molecular imaging community. We briefly review methodologies for molecular imaging by magnetic resonance imaging and optical methods. Special emphasis is put on different contrast agent designs (e.g., targeted and smart probes). New technical developments in optical imaging are briefly discussed. In addition, current research results are put into a clinical perspective to elucidate the potential merits one might expect from this new research field.
Collapse
|
45
|
Matuszewski CC, Persigehl T, Wall A, Meier N, Kessler T, Tombach B, Mesters R, Heindel W, Bremer C. Abschätzung der medullären Angiogenese im Rahmen der akuten myeloischen Leukämie (AML) mithilfe der Eisenoxid-unterstützten KM-MRT. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-864014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
46
|
Wall A, Persigehl T, Wallbrunn AV, Matuszewski L, Ottovalk I, Heindel W, Bremer C. Membranselektive Fluoreszenzmarkierung für in-vitro und in-vivo Zelldetektion. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-864011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Persigehl T, Matuszewski L, Wall A, Bieker R, Meier N, Kessler T, Berdel W, Mesters R, Heindel W, Bremer C. Monitoring anti-angiogener Tumortherapie mittels Eisenoxid unterstützter MRT. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-864012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Bremer C. Imaging of proteases for tumor detection and differentiation. ERNST SCHERING RESEARCH FOUNDATION WORKSHOP 2004:159-70. [PMID: 15524216 DOI: 10.1007/3-540-26809-x_9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
|
49
|
Matuszewski L, Wall A, Persigehl T, Meier N, Tombach B, Mesters R, Heindel W, Bremer C. Abschätzung der medullären Angiogenese im Rahmen der akuten myeloischen Leukämie (AML) mit Hilfe der Eisenoxid-unterstützten KM-MRT. ROFO-FORTSCHR RONTG 2004. [DOI: 10.1055/s-2004-827893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
Persigehl T, Matuszewski L, Wall A, Bieker R, Berdel W, Mesters R, Heindel W, Bremer C. Monitoring anti-angiogener Tumortherapie mittels Eisenoxid unterstützter MRT. ROFO-FORTSCHR RONTG 2004. [DOI: 10.1055/s-2004-827642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|